High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The tumor suppressor gene wt1 (Wilms' tumor gene) encodes for a zinc finger DNA-binding protein with predominantly transcription repressing properties. Because wt1 has been shown to be expressed in the vast majority of patients with acute myeloid leukemias (AML), we investigated the relevance of wt-1 mRNA expression regarding prognosis and possible prediction of relapse during follow-up. Totally bone marrow-derived blasts of 139 AML patients (129 newly diagnosed AML patients, 22 AML patients again in first relapse, and 10 AML patients analyzed primarily in first relapse) were studied for wt1 mRNA expression. Seventy-seven patients were analyzed for wt1 mRNA expression during follow-up. wt1-specific reverse transcription-polymerase chain reaction (RT-PCR) was performed and the amplification product was visually classified as not, weakly, moderately, or strongly amplified, as described previously. PCR products were quantitated by competitive PCR using a shortened homologous wt1 construct standard in representative cases. The expression of wt1 transcripts was correlated to age, French-American-British (FAB) subtype, phenotype, karyotype, and long-term survival. wt1 mRNA was detectable in 124 of 161 (77%) samples at diagnosis and in first relapse. wt1 expression was independent from age, antecedent myelodysplastic syndrome or FAB subtype, with the exception of a significant difference in M5 leukemias showing wt1 transcripts in only 40% (P = .0025). There was no correlation between the level of wt1 mRNA and response to treatment or the prognostic groups defined by the karyotype. Concerning long-term survival, patients with high levels of wt1 had a significantly worse overall survival (OS) than those with not detectable or low levels. The 3-year OS for all newly diagnosed AMLs was 13% and 38% (P = .038), respectively, and 12% and 43% (P = .014) for de novo AMLs. The difference was more distinct in patients less than 60 years of age. During follow-up, all patients achieving complete remission became wt1 negative. Reoccurrence of wt1 transcripts predicted relapse. The data indicate that high expression of wt1 mRNA is associated with a worse long-term prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., & Arnheim, N. (1985) · Science · doi:10.1126/science.2999980 · Cited by 8,956
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Bennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,602
BENNETT, J. M., CATOVSKY, D., DANIEL, M. T., FLANDRIN, G., GALTON, D. A. G., GRALNICK, H. R., & SULTAN, C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-620 · Cited by 2,926
WT-1 is required for early kidney development
Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., & Jaenisch, R. (1993) · Cell · doi:10.1016/0092-8674(93)90515-r · Cited by 1,989
Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Kral, A., Yeger, H., Lewis, W. H., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90601-a · Cited by 1,876
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
Gessler, M., Poustka, A., Cavenee, W., Neve, R. L., Orkin, S. H., & Bruns, G. A. P. (1990) · Nature · doi:10.1038/343774a0 · Cited by 1,292
Schibler, U., Wyler, T., & Hagenbüchle, O. (1975) · Journal of Molecular Biology · doi:10.1016/0022-2836(75)90217-x · Cited by 1,188
The candidate Wilms' tumour gene is involved in genitourinary development
Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D., et al. (1990) · Nature · doi:10.1038/346194a0 · Cited by 864
Becker-André, M., & Hahlbrock, K. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.22.9437 · Cited by 652
Alternative splicing and genomic structure of the Wilms tumor gene WT1.
Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M., & Housman, D. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9618 · Cited by 620
Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., & Nasu, K. (1994) · Blood · doi:10.1182/blood.v84.9.3071.3071 · Cited by 575
Repression of the Insulin-Like Growth Factor II Gene by the Wilms Tumor Suppressor WT1
Drummond, L. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., Sukhatme, V. P., & Rauscher, F. J. (1992) · Science · doi:10.1126/science.1323141 · Cited by 525
Expression of the Wilms' tumor gene (WT1) in human leukemias.
Miwa, H., Beran, M., & Saunders, G. F. (1992) · PubMed · Cited by 349
Menssen, H. D., Renkl, H., Rodeck, U., Maurer, J., Notter, M., Schwartz, S., Reinhardt, R., & Thiel, E. (1995) · PubMed · Cited by 299
Joseph, L. J., Le Beau, M. M., Jamieson, G. A., Acharya, S., Shows, T. B., Rowley, J. D., & Sukhatme, V. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7164 · Cited by 292
Yamagami, T., Sugiyama, H., Inoue, K., Ogawa, H., Tatekawa, T., Hirata, M., Kudoh, T., Akiyama, T., Murakami, A., & Maekawa, T. (1996) · Blood · doi:10.1182/blood.v87.7.2878.bloodjournal8772878 · Cited by 251
Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
Hewitt, S. M., Hamada, S., McDonnell, T. J., Rauscher, F. J., & Saunders, G. F. (1995) · PubMed · Cited by 200
Inoue, K., Ogawa, H., Yamagami, T., Soma, T., Tani, Y., Tatekawa, T., Oji, Y., Tamaki, H., Kyo, T., Dohy, H., et al. (1996) · Blood · doi:10.1182/blood.v88.6.2267.bloodjournal8862267 · Cited by 183
Harrington, M. A., Konicek, B., Song, A., Xia, X. L., Fredericks, W. J., & Rauscher, F. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36920-0 · Cited by 170
Mutations in the Wilms' tumor gene WT1 in leukemias
King-Underwood, L., Renshaw, J., & Pritchard-Jones, K. (1996) · Blood · doi:10.1182/blood.v87.6.2171.bloodjournal8762171 · Cited by 167
Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells.
Miyagi, T., Ahuja, H. G., Kubota, T., Kubonishi, I., Koeffler, H. P., & Miyoshi, I. (1993) · PubMed · Cited by 165
The WT1 Wilms' tumor suppressor gene: How much do we really know?
Reddy, J. C., & Licht, J. D. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00014-7 · Cited by 162
Brieger, J., Weidmann, E., Fenchel, K., Mitrou, P. S., Hoelzer, D. T., & Bergmann, L. (1994) · PubMed · Cited by 116
Self-citationDownregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells
Sekiya, M., Adachi, M., Hinoda, Y., Imai, K., & Yachi, A. (1994) · Blood · doi:10.1182/blood.v83.7.1876.1876 · Cited by 106
Phelan, S. A., Lindberg, C., & Call, K. M. (1994) · PubMed · Cited by 80
Bergmann, L., Heil, G., Kolbe, K., Lengfelder, E., Puzicha, E., Martin, H., Lohmeyer, J., Mitrou, P. S., & Hoelzer, D. F. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509049766 · Cited by 48
Self-citationBrieger, J., Weidmann, E., Maurer, U., Hoelzer, D. T., Mitrou, P. S., & Bergmann, L. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059321 · Cited by 46
Self-citationWT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
Haber, D. A., & Buckler, A. (1992) · PubMed · Cited by 46
Molecular mechanisms possibly affecting WT1 function in human ovarian tumors
Viel, A., Giannini, F., Capozzi, E., Canzonieri, V., Scarabelli, C., Gloghini, A., & Boiocchi, M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570413 · Cited by 37
Cited by
van der Velden, V. H. J., Hochhaus, A., Cazzaniga, G., Szczepanski, T., Gabert, J., & van Dongen, J. J. M. (2003) · Leukemia · doi:10.1038/sj.leu.2402922 · Cited by 563
Oka, Y., Tsuboi, A., Taguchi, T., Osaki, T., Kyo, T., Nakajima, H., Elisseeva, O. A., Oji, Y., Kawakami, M., Ikegame, K., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405884101 · Cited by 531
A tumor suppressor and oncogene: the WT1 story
Yang, L., Han, Y., Saurez Saiz, F., & Minden, M. D. (2007) · Leukemia · doi:10.1038/sj.leu.2404624 · Cited by 471
Saito, Y., Kitamura, H., Hijikata, A., Tomizawa-Murasawa, M., Tanaka, S., Takagi, S., Uchida, N., Suzuki, N., Sone, A., Najima, Y., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000349 · Cited by 458
Haematopoietic cell transplantation as immunotherapy
Appelbaum, F. R. (2001) · Nature · doi:10.1038/35077251 · Cited by 411
Metadata
- Authors
- Bergmann, L., Miething, C., Maurer, U., Brieger, J., Karakas, T., Weidmann, E., & Hoelzer, D.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1997-08-01
- Volume
- 90
- Issue
- 3
- Pages
- 1217-1225
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W227961483
- Cited by
- 354
- References
- 34
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.